Detection of<i>Helicobacter pylori</i>resistance to clarithromycin and fluoroquinolones in Brazil: A national survey

Abstract

The H. pylori clarithromycin resistance rate in Brazil is at the borderline (15%-20%) for applying the standard triple therapy. The fluoroquinolone resistance rate (13.5%) is equally concerning.